These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36290100)

  • 1. An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational
    Laws TR; Barnes KB; Jenner DC; Núñez A; Richards MI; Thwaite JE; Vente A; Rushton D; Nelson M; Harding SV
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290100
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.
    Barnes KB; Hamblin KA; Richards MI; Laws TR; Vente A; Atkins HS; Harding SV
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438936
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of finafloxacin in a murine model of inhalational glanders.
    Barnes KB; Bayliss M; Davies C; Richards MI; Laws TR; Vente A; Harding SV
    Front Microbiol; 2022; 13():1057202. PubMed ID: 36504783
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.
    Barnes KB; Steward J; Thwaite JE; Lever MS; Davies CH; Armstrong SJ; Laws TR; Roughley N; Harding SV; Atkins TP; Simpson AJ; Atkins HS
    Int J Antimicrob Agents; 2013 Jun; 41(6):552-7. PubMed ID: 23517714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of a combination therapy approach for the treatment of melioidosis.
    Barnes KB; Richards MI; Burgess G; Armstrong SJ; Bentley C; Maishman TC; Laws TR; Nelson M; Harding SV
    Front Microbiol; 2022; 13():934312. PubMed ID: 36051754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole.
    Sivalingam SP; Sim SH; Jasper LC; Wang D; Liu Y; Ooi EE
    J Antimicrob Chemother; 2008 Mar; 61(3):674-8. PubMed ID: 18192684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized
    Nelson M; Barnes KB; Davies CH; Cote CK; Meinig JM; Biryukov SS; Dyer DN; Frick O; Heine H; Pfefferle DA; Horstman-Smith A; Barbaras J; Harding SV
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978372
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential of repurposing chloroquine as an adjunct therapy for melioidosis based on a murine model of Burkholderia pseudomallei infection.
    Ganesan N; Embi N; Hasidah MS
    Trop Biomed; 2020 Jun; 37(2):303-317. PubMed ID: 33612800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Resistance to Folate Pathway Inhibitors in
    Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis.
    Thomas RJ; Davies C; Nunez A; Hibbs S; Eastaugh L; Harding S; Jordan J; Barnes K; Oyston P; Eley S
    Front Cell Infect Microbiol; 2012; 2():101. PubMed ID: 22919690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependant acute or subacute disease caused by Burkholderia pseudomallei strain NCTC 13392 in a BALB/c aerosol model of infection.
    Funnell SGP; Tree JA; Hatch GJ; Bate SR; Hall G; Pearson G; Rayner EL; Roberts ADG; Vipond J
    J Appl Microbiol; 2019 Oct; 127(4):1224-1235. PubMed ID: 31330088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses.
    See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.
    Bearss JJ; Hunter M; Dankmeyer JL; Fritts KA; Klimko CP; Weaver CH; Shoe JL; Quirk AV; Toothman RG; Webster WM; Fetterer DP; Bozue JA; Worsham PL; Welkos SL; Amemiya K; Cote CK
    PLoS One; 2017; 12(2):e0172627. PubMed ID: 28235018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Within-Host Evolution of
    Viberg LT; Sarovich DS; Kidd TJ; Geake JB; Bell SC; Currie BJ; Price EP
    mBio; 2017 Apr; 8(2):. PubMed ID: 28400528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.
    Leakey AK; Ulett GC; Hirst RG
    Microb Pathog; 1998 May; 24(5):269-75. PubMed ID: 9600859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice.
    Lever MS; Nelson M; Stagg AJ; Beedham RJ; Simpson AJ
    Int J Exp Pathol; 2009 Feb; 90(1):16-25. PubMed ID: 19200247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model.
    Ulett GC; Hirst R; Bowden B; Powell K; Norton R
    J Antimicrob Chemother; 2003 Jan; 51(1):77-81. PubMed ID: 12493790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
    Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
    PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.